Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) EPS (Basic) (2016 - 2025)

Sanara MedTech (SMTI) has disclosed EPS (Basic) for 15 consecutive years, with $0.72 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Basic) rose 157.14% year-over-year to $0.72, compared with a TTM value of -$0.72 through Sep 2025, down 94.59%, and an annual FY2024 reading of -$1.14, down 119.23% over the prior year.
  • EPS (Basic) was $0.72 for Q3 2025 at Sanara MedTech, up from -$0.23 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.72 in Q3 2025 and bottomed at -$0.8 in Q4 2024.
  • Average EPS (Basic) over 5 years is -$0.19, with a median of -$0.21 recorded in 2024.
  • Peak annual rise in EPS (Basic) hit 315.38% in 2024, while the deepest fall reached 2566.67% in 2024.
  • Year by year, EPS (Basic) stood at -$0.48 in 2021, then decreased by 6.25% to -$0.51 in 2022, then soared by 94.12% to -$0.03 in 2023, then plummeted by 2566.67% to -$0.8 in 2024, then skyrocketed by 190.0% to $0.72 in 2025.
  • Business Quant data shows EPS (Basic) for SMTI at $0.72 in Q3 2025, -$0.23 in Q2 2025, and -$0.41 in Q1 2025.